Jesse Cohn · Elliott Investment Management
Elliott Management's letter to the athenahealth board proposing a take-private (May 2018)
Published 7 May 2018Available at SEC.gov, link checked 7 Oct 2026Activist letter · Investment
The view as filed on 7 May 2018, not a statement of what the author thinks today.
What to notice
- 1
Elliott lists execution failures: five CFOs in four years, a long-held 30% operating margin target against 14% achieved in 2017, and 2017 bookings guidance cut twice and still missed.
Continue the investment thesis
See the 3 remaining takeaways on what this investor is arguing and why, and every analysis across the Letters & Theses library.
Checking what you can open…
“athenahealth as a public-company investment, despite all of its promise, has not worked for many years”
Why read it
Shows an activist turning into a bidder: the case against a company's public-market record, followed by the price, premium, financing and diligence terms of a take-private proposal.
About this letter
Jesse Cohn, partner and senior portfolio manager at Elliott Management, wrote this letter to the board of athenahealth on 7 May 2018. Elliott's funds owned common stock and economic equivalents representing 8.9% of the company, and the full text was filed with the SEC in an amendment to Elliott's Schedule 13D alongside a press release.
The letter follows a year of private engagement with management and the board, and a private approach in November about a possible take-private, which Elliott says the company refused to discuss. It now proposes publicly that Elliott acquire athenahealth for $160 per share in cash. The letter is organised under five headings: background to the proposal, Elliott's experience in private equity, details and financing, due diligence requirements, and next steps. Much of the background section is a critique of the company's record as a public investment.
Companies
- athenahealth
Themes
- governance
- turnaround
- management change
- strategy
L3VLUP does not host this document. It belongs to Elliott Investment Management and is a public SEC filing; the notes above are L3VLUP’s reading of it.
More from Elliott Investment Management
The same argument, elsewhere
- Trian's March 2024 letter to Disney shareholders · Trian Fund Management
- Starboard Value's letter to CarMax's incoming CEO · Jeffrey Smith, Starboard Value
- Broadwood Partners' letter to STAAR Surgical shareholders, against the sale to Alcon · Neal Bradsher, Broadwood Capital
- JANA Partners' second letter to Lamb Weston's board, on what shareholders told it · Scott Ostfeld, JANA Partners